暫無數據
代碼股票名稱
最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業
美股市場個股詳情
ARVN Arvinas
- 32.370
- +0.770+2.44%
收盤價 04/26 16:00 (美東)
- 31.740
- -0.630-1.95%
盤後 17:01 (美東)
22.11億總市值-4889市盈率TTM
32.720最高價31.040最低價77.87萬股成交量31.730今開31.600昨收2507.92萬成交額1.48%換手率虧損市盈率(靜)6830.84萬總股本53.08052周最高3.35市淨率17.03億流通值13.57052周最低--股息TTM5260.28萬流通股108.465歷史最高--股息率TTM5.32%振幅10.190歷史最低32.205平均價1股每手
全部分時
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
資金分布
單位: --
資金流向
實時日周月
暫無數據
新聞
快訊 | Arvinas 任命 Randy Teel 博士爲首席商務官
Arvinas 任命 Randy Teel 博士爲首席商務官
康涅狄格州紐黑文，2024年4月24日（GLOBE NEWSWIRE）——Arvinas, Inc.（納斯達克股票代碼：ARVN）是一家基於靶向蛋白質降解開發新藥物的臨床階段生物技術公司，今天
分析師對Arvinas, Inc.（納斯達克股票代碼：ARVN）的預測正在飆升
Arvinas, Inc.（納斯達克股票代碼：ARVN）的股東今天將有理由微笑，分析師對今年的法定預測進行了大幅上調。分析師們大大提高了他們的投資回報率
HC Wainwright & Co.：維持Arvinas(ARVN.US)評級，由買入調整至買入評級, 目標價由90.00美元調整至87.00美元。
HC Wainwright & Co.：維持Arvinas(ARVN.US)評級，由買入調整至買入評級, 目標價由90.00美元調整至87.00美元。
快訊 | HC Wainwright & Co.維持對Arvinas的買入，將目標股價下調至87美元
諾華（NVS）與ARVN的前列腺癌候選藥物達成協議
評論
Arvinas' high P/S ratio could be worrisome as revenue forecasts are not promising. The anticipated future revenues may not sustain the current positive sentiment. Without significant improvements, these prices may not be deemed reasonable.
Revenues Not Telling The Story For Arvinas, Inc. (NASDAQ:ARVN) After Shares Rise 28% 1
Sean Cassidy expressed confidence in the company's future and the promising clinical development and commercial opportunity for the PROTAC(R) protein degrader pipeline. The company's leadership acknowledged Cassidy's pivotal role in creating Arvinas' strong financial profile.
1
$Arvinas(ARVN.US$ 👀 new hoy
$Arvinas(ARVN.US$ I hope everyone bought that sub 14 dip! This thing has been a beast.
1
專欄Top upgrades and downgrades on 6/21: XOM, ADBE, UAA, BEKE and more
Upgrades
• $反導工業(ABM.US$ : Baird Upgrades to Outperform from Neutral - PT $50
• $美國電塔(AMT.US$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $丘奇&德懷特(CHD.US$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy(CHWY.US$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $康西哥(CNC.US$ : Credit Suisse Upgrades to Outperform from...
• $反導工業(ABM.US$ : Baird Upgrades to Outperform from Neutral - PT $50
• $美國電塔(AMT.US$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $丘奇&德懷特(CHD.US$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy(CHWY.US$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $康西哥(CNC.US$ : Credit Suisse Upgrades to Outperform from...
16
閱讀更多
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅